California AB1103: Controlled substances research review and approval.
California AB1103 amends the California Uniform Controlled Substances Act to establish a Research Advisory Panel for reviewing and approving research projects involving Schedule I or II controlled substances. The panel can expedite reviews for projects meeting specific criteria, such as independent peer review and federal approvals. The bill also outlines conditions under which state bodies can hold closed sessions, including discussions on litigation, eminent domain, and other sensitive matters.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.